Obesity, which is a worldwide epidemic, confers increased risk for multiple serious
conditions including type 2 diabetes, nonalcoholic fatty liver disease, and cardiovascular …

NAFLD is the world's most common chronic liver disease, and its increasing prevalence
parallels the global rise in diabetes and obesity. It is characterised by fat accumulation in the …

Context The burden of cirrhosis from nonalcoholic fatty liver disease (NAFLD) is reaching
epidemic proportions in the United States. This calls for greater awareness among …

Nonalcoholic fatty liver disease (NAFLD) is a leading etiology for chronic liver disease with
an immense public health impact and affects> 25% of the US and global population. Up to 1 …

Background Non-alcoholic fatty liver disease (NAFLD) is a clinicopathologic entity that
requires a liver biopsy assessment to diagnose the progressive form of NAFLD called non …

Human sex hormone-binding globulin (SHBG) is a glycoprotein produced by the liver that
binds sex steroids with high affinity and specificity. Clinical observations and reports in the …

Consumption of fructose, the sweetest of all naturally occurring carbohydrates, has
increased dramatically in the last 40 years and is today commonly used commercially in soft …

Background And Aims Insulin resistance is a key factor in the pathogenesis of nonalcoholic
fatty liver disease (NAFLD). We evaluated the importance of subcutaneous abdominal …

Objective This study assessed the impact of diabetes mellitus (DM) on nonalcoholic fatty
liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) with advanced fibrosis …

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …